Jeremy Hamm

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

William Morris, Scott Tyldesley, S. Rodda et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 732 citations

Medicine, Oncology, Radiation Oncology +17

ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer

Scott Tyldesley, William Morris, Mira Keyes et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 316 citations

Medicine, Oncology, Radiation Oncology +17

ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer

S. Rodda, William Morris, Jeremy Hamm et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 98 citations

Medicine, Oncology, Radiation Oncology +16

ASCENDE-RT*: A multicenter, randomized trial of dose-escalated external beam radiation therapy (EBRT-B) versus low-dose-rate brachytherapy (LDR-B) for men with unfavorable-risk localized prostate cancer.

William Morris, Scott Tyldesley, Howard Pai et al. · Journal of Clinical Oncology · 2015 · 96 citations

Medicine, Oncology, Radiation Oncology +17

An Updated Analysis of the Survival Endpoints of ASCENDE-RT

Justin Oh, Scott Tyldesley, Howard Pai et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 60 citations

Public Health, Biostatistics, Oncology +10